Medicine and Dentistry
Glomerulosclerosis
100%
Nephropathy
100%
Nephrotic Syndrome
80%
Disease
60%
Antibodies
60%
Kidney Function
60%
Myelopoiesis
40%
Immune System
40%
Kidney Injury
40%
Immunity
40%
End Stage Renal Disease
20%
In Vitro
20%
Recurrent Disease
20%
Myeloid Cell
20%
Hematopoiesis
20%
Urokinase Receptor
20%
Granulocyte
20%
Chronic Inflammation
20%
Cell Differentiation
20%
Glomerulopathy
20%
Secretion (Process)
20%
Patient Experience
20%
Side Effect
20%
Blood Cell
20%
Cytokine
20%
Interleukin 6
20%
Hematopoietic Cell
20%
Keyphrases
Renal Disease
100%
Bone Marrow
100%
Soluble Urokinase Plasminogen Activator Receptor (suPAR)
66%
Focal Segmental Glomerulosclerosis
55%
Nephrotic Syndrome
44%
Tumor Necrosis Factor-α
44%
Immune Factors
33%
Inflammation
22%
Renal Function
22%
Proteinuric Kidney Disease
22%
Renal Injury
22%
Myelopoiesis
22%
Bone Marrow Cells
11%
Bone Marrow-derived Monocytes
11%
Novel Therapies
11%
Glomerular Disease
11%
Immune Alterations
11%
Inflammatory Cytokines
11%
Hematopoiesis
11%
CD14+CD16+
11%
Interleukin-6
11%
Recurring
11%
Blood Cell Production
11%
Hematopoietic Stem Cell Differentiation
11%
Transplanted Kidney
11%
In Vitro Assay
11%
Non-family
11%
Immature Myeloid Cells
11%
Central Regulator
11%
Interleukin-8
11%
Current Treatment
11%
Immune System
11%
Monocytic
11%
Immune Signature
11%
Immune Activation
11%
Granulocytes
11%
Kidney Function
11%
Inflammatory Pathways
11%
Patient Experience
11%
Chronic Inflammation
11%
Most Common Cause
11%
Treatment Options
11%
Soluble Factors
11%
Prevent Recurrence
11%
Recurrent Disease
11%
Kidney Disease
11%
Upstream Regulator
11%
INIS
bone marrow
100%
diseases
100%
kidneys
100%
inflammation
45%
patients
36%
production
27%
data
18%
injuries
18%
stem cells
9%
secretion
9%
cell differentiation
9%
levels
9%
plasma
9%
in vitro
9%
blood cells
9%
hematopoiesis
9%
side effects
9%
monocytes
9%
losses
9%
urokinase
9%
therapy
9%
granulocytes
9%
corrections
9%
receptors
9%
adults
9%
pathogenesis
9%
cytokines
9%
mice
9%
hypothesis
9%
signals
9%
stratification
9%